The $1.1 Billion Paradox: Inside Emcure’s High-Stakes Legal Warfare, US FDA Scrutiny, and Leadership Exodus
10 min read
An executive ousting, an entire dermatology unit in freefall, a mass exodus of 950 employees, and a high-stakes EOW criminal complaint. As Emcure hits the... Read More

NCLT Hyderabad Clears Resolution Plan: Beaufond Industries to Acquire Kobo Biotech as Going Concern
Beaufond Plc Charts European Course: Advanced Negotiations Under Way for Strategic API Supply Alliance with Netherlands Pharmaceutical Group
US–Iran Standoff: A Global Flashpoint – Power Politics Overrule Diplomacy
United States Supreme Court Schools Donald Trump: A Historic Rebuke of Executive Overreach
From Generics to Genius: India’s Pharma Awakens to Global Leadership
Shashi Tharoor Tears Into Union Budget 2026–27: “Promises Without Commitment”
India–US Trade Deal Secures Lifeline for Affordable Generics – Dr Dilip Surana
Union Budget 2026: Growth for Bharat, Relief Deferred!
Budget 2026: Nirmala Sitharaman’s Tightrope Walk Between Growth and Justice